DBV Technologies ADR (NASDAQ: DBVT)’s stock price has increased by 62.15 compared to its previous closing price of 3.91. However, the company has seen a 27.05% increase in its stock price over the last five trading sessions. marketwatch.com reported 2025-03-28 that American depositary receipts of DBV Technologies gained after the company reported new financing of up to $306.9 million.
Is It Worth Investing in DBV Technologies ADR (NASDAQ: DBVT) Right Now?
Additionally, the 36-month beta value for DBVT is 0.25. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for DBVT is 20.50M and currently, short sellers hold a 1.66% ratio of that float. The average trading volume of DBVT on March 28, 2025 was 62.34K shares.
DBVT’s Market Performance
DBVT stock saw an increase of 27.05% in the past week, with a monthly gain of 50.95% and a quarterly increase of 108.55%. The volatility ratio for the week is 11.41%, and the volatility levels for the last 30 days are 9.23% for DBV Technologies ADR (DBVT). The simple moving average for the last 20 days is 37.91% for DBVT stock, with a simple moving average of 56.38% for the last 200 days.
Analysts’ Opinion of DBVT
Goldman gave a rating of “Neutral” to DBVT, setting the target price at $1.50 in the report published on May 10th of the previous year.
DBVT Trading at 42.67% from the 50-Day Moving Average
After a stumble in the market that brought DBVT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.78% of loss for the given period.
Volatility was left at 9.23%, however, over the last 30 days, the volatility rate increased by 11.41%, as shares surge +43.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +31.28% upper at present.
During the last 5 trading sessions, DBVT rose by +27.86%, which changed the moving average for the period of 200-days by +22.69% in comparison to the 20-day moving average, which settled at $4.60. In addition, DBV Technologies ADR saw 105.18% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DBVT starting from Mohideen Pharis, who sale 600 shares at the price of $0.85 back on Jan 30 ’25. After this action, Mohideen Pharis now owns 110,510 shares of DBV Technologies ADR, valued at $510 using the latest closing price.
Mohideen Pharis, the Chief Medical Officer of DBV Technologies ADR, sale 565 shares at $0.57 during a trade that took place back on Nov 25 ’24, which means that Mohideen Pharis is holding 111,110 shares at $322 based on the most recent closing price.
Stock Fundamentals for DBVT
Current profitability levels for the company are sitting at:
- -9.15 for the present operating margin
- 1.0 for the gross margin
The net margin for DBV Technologies ADR stands at -8.92. The total capital return value is set at -1.68. Equity return is now at value -135.93, with -91.60 for asset returns.
Based on DBV Technologies ADR (DBVT), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -13.05.
Currently, EBITDA for the company is -87.46 million with net debt to EBITDA at 0.38. When we switch over and look at the enterprise to sales, we see a ratio of 8.04. The receivables turnover for the company is 0.57for trailing twelve months and the total asset turnover is 0.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.22.
Conclusion
In conclusion, DBV Technologies ADR (DBVT) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
